NCT01391663 Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean Participants Status COMPLETED Phase PHASE1
NCT01390545 VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis Status TERMINATED Phase PHASE2
NCT01364649 Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction Status COMPLETED Phase PHASE3
NCT01355081 Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT01350999 Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia Status COMPLETED Phase PHASE3
NCT01350973 Efficacy of TAK-085 in Participants With Hypertriglyceridemia Status COMPLETED Phase PHASE3
NCT01350388 Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease Status COMPLETED Phase NA
NCT01328652 Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy Status UNKNOWN Phase PHASE4
NCT01318135 Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan Status COMPLETED Phase PHASE2/PHASE3
NCT01318122 Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan Status COMPLETED Phase PHASE2/PHASE3
NCT01318109 Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan Status COMPLETED Phase PHASE2/PHASE3
NCT01318083 Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan Status COMPLETED Phase PHASE2/PHASE3
NCT01318070 Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan Status COMPLETED Phase PHASE2/PHASE3
NCT01317797 A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT01309828 Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease Status COMPLETED Phase PHASE3
NCT01299805 Effects of Vortioxetine (Lu AA21004) on the Concentrations of Selected Neurotransmitters in Healthy Male Adults Status COMPLETED Phase PHASE1
NCT01289132 Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension Status COMPLETED Phase PHASE2